We compared the 13 telehealth clinics prescribing semaglutide, tirzepatide, Wegovy, and Zepbound across pricing, medications, insurance, and visit type so you can find the right fit in minutes
Cytometry 17(1):84-93, 1994
Losing weight on GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may increase your risk of developing nutrient deficiencies because these medications cause people to significantly reduce their food intake
Given the dose-dependent effects and improved management of tolerability within the GLP-1RA class, the aim of this trial was to characterize the dose-dependent effects of subcutaneous semaglutide at doses up to 16 mg weekly (2 mg, 8 mg, 16 mg, and pooled placebo) in individuals with type 2 diabetes and overweight or obesity (BMI 27 kg/m 2 )
Both medication classes effectively lower blood glucose when appropriately selected for individual patient needs
The other study that I wanted to touch upon for this elecoglipron agent is VISTA, which is obesity without diabetes